Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 09, 2021

SELL
$2.62 - $3.45 $411,340 - $541,650
-157,000 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$1.96 - $3.15 $307,720 - $494,550
157,000 New
157,000 $495,000
Q1 2021

May 14, 2021

SELL
$1.89 - $2.96 $551,250 - $863,334
-291,667 Closed
0 $0
Q4 2020

Feb 11, 2021

BUY
$0.65 - $1.94 $189,583 - $565,833
291,667 New
291,667 $566,000

Others Institutions Holding VTGN

About VistaGen Therapeutics, Inc.


  • Ticker VTGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 206,836,000
  • Market Cap $730M
  • Description
  • VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...
More about VTGN
Track This Portfolio

Track Monashee Investment Management LLC Portfolio

Follow Monashee Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Monashee Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Monashee Investment Management LLC with notifications on news.